Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

18 results
Display

ASGO 5th International Workshop on Gynecologic Oncology

Son JH, Chang SJ, Ryu HS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States

Matsuo K, Machida H, Mandelbaum RS, Mikami M, Enomoto T, Roman LD, Wright JD

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical utility of CA-125 in the management of uterine carcinosarcoma

Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura , Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current landscape and future perspective of sentinel node mapping in endometrial cancer

Bogani G, Raspagliesi F, Leone Roberti Maggiore U, Mariani A

Endometrial cancer (EC) represents the most common gynecological neoplasm in developed countries. Surgery is the mainstay of treatment for EC. Although EC is characterized by a high prevalence several features...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of the pulmonary recruitment maneuver on pain after laparoscopic gynecological oncologic surgery: a prospective randomized trial

Güngördük K, Aşıcıoğlu O, Özdemir I

OBJECTIVE: To evaluate the effectiveness of the pulmonary recruitment maneuver (PRM) at the end of the operation to decrease laparoscopy-induced abdominal or shoulder pain after gynecological oncologic surgery. METHODS: In total,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Robotic lower pelvic port placement for optimal upper paraaortic lymph node dissection

Paek J, Kang E, Lim PC

OBJECTIVE: Upper paraaortic lymph node dissection (UPALD) to the infrarenal level is one of the most challenging robotic procedures. Because robotic system has the limitation in robotic arm mobility. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?

Lee MX, Tan DS

The 3-weekly regimen of carboplatin and paclitaxel is the backbone of first line adjuvant chemotherapy for advanced ovarian cancer. The landmark Japanese Gynaecologic Oncology Group (JGOG) 3016 study demonstrated significant...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study

Uccella S, Falcone F, Greggi S, Fanfani F, De Iaco P, Corrado G, Ceccaroni , Mandato VD, Bogliolo S, Casarin J, Monterossi G, Pinelli C, Mangili G, Cormio G, Roviglione G, Bergamini , Pesci A, Frigerio L, Uccella S, Vizza E, Scambia G, Ghezzi F

OBJECTIVE: To investigate survival outcomes in endometrioid endometrial cancer (EEC) patients with single vs. multiple positive pelvic lymph nodes. METHODS: We performed a retrospective evaluation of all consecutive patients with histologically...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Checkpoint-inhibition in ovarian cancer: rising star or just a dream?

Pietzner K, Nasser S, Alavi S, Darb-Esfahani S, Passler M, Muallem MZ, Sehouli J

The introduction of checkpoint inhibitors revolutionized immuno-oncology. The efficacy of traditional immunotherapeutics, like vaccines and immunostimulants was very limited due to persistent immune-escape strategies of cancer cells. Checkpoint inhibitors target...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Quality indicators for cervical cancer care in Japan

Watanabe T, Mikami M, Katabuchi , Kato S, Kaneuchi M, Takahashi , Nakai H, Nagase S, Niikura H, Mandai M, Hirashima , Yanai H, Yamagami W, Kamitani S, Higashi T

OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix

Matsuo K, Mandelbaum RS, Machida H, Purushotham S, Grubbs BH, Roman LD, Wright JD

OBJECTIVE: To examine the association between tumor grade and survival for women with squamous cervical cancer. METHODS: This retrospective observational study utilized the Surveillance, Epidemiology, and End Result program data between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion

Cushman TR, Haque W, Menon H, Rusthoven , Butler EB, Teh BS, Verma V

OBJECTIVE: Women with cervical cancer (CC) found to have positive surgical margins, positive lymph nodes, and/or parametrial invasion receive a survival benefit from postoperative chemoradiotherapy (CRT) vs. radiation therapy (RT)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p

Luan X, Wang Y

OBJECTIVE: Cervical cancer is one of the most common malignant tumors. Our previous results showed that long non-coding RNA (lncRNA) XLOC_006390 plays an important role in cervical cancer. In this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide

Kanno T, Matsui H, Akizawa Y, Usui H, Shozu M

OBJECTIVE: Highly effective chemotherapy for patients with low-risk gestational trophoblastic neoplasia (GTN) is associated with almost a 100% cure rate. However, 20%–30% of patients treated with chemotherapy need to change...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study

Baek MH, Kim DY, Kim SO, Kim YJ, Park YH

OBJECTIVE: The impact of beta blockers (BBs) on survival outcomes in ovarian cancer was investigated. METHODS: By using Korean National Health Insurance Service Data, Cox proportional hazards regression was performed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea

Kim DH, Cho CH, Kwon SY, Ryoo NH, Jeon DS, Lee W, Ha JS

OBJECTIVE: We performed small-scale mutation and large genomic rearrangement (LGR) analysis of BRCA1/2 in ovarian cancer patients to determine the prevalence and the characteristics of the mutations. METHODS: All ovarian cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p

Wang C, Qi S, Xie C, Li C, Wang P, Liu D

OBJECTIVE: The present study is to evaluate the biological functions of long non-coding RNA (lncRNA), X-inactive specific transcript, X-inactive specific transcript (XIST) in human epithelial ovarian cancer (EOC). METHODS: XIST was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis

Han S, Woo S, Suh CH, Lee JJ

OBJECTIVE: We describe a systematic review and meta-analysis of the performance of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) for detecting metastasis in ovarian cancer. METHODS: MEDLINE and Embase were searched...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr